OGEN Oragenics Inc.

0.93
-0.02  -2%
Previous Close 0.95
Open 0.97
Price To Book 3.88
Market Cap 27372816
Shares 29,433,135
Volume 528,654
Short Ratio 1.08
Av. Daily Volume 1,823,809

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 top-line data due late-2019.
AG013
Oral mucositis (OM)

Latest News

  1. OGEN: New Preclinical Research Confirms OG716 Potential in Treating C. Difficile Infection…
  2. Oragenics, Inc. Receives Further Validation for Lantibiotic Compound OG716
  3. Oragenics Inc. to Present at NobleCon15 on January 28, 2019
  4. Oragenics Fast Track Drug AG013 Going into Phase II Clinicals, Pipeline Review
  5. Today's Research Reports on Trending Tickers: Oragenics and Intec Pharma
  6. Oragenics, Inc. Announces Publication Detailing the Development of Blueprints for Designing a New Class of Anti-Infectives
  7. Oragenics, Inc. to Present at the 11th Annual LD Micro Main Event
  8. Recent Analysis Shows Liberty Global, New Oriental Education & Technology Group, Platinum Group Metals, Asure Software, Oragenics, and MGE Energy Market Influences — Renewed Outlook, Key Drivers of Growth
  9. OGEN: Phase 2 Trial of AG013 Adds Clinical Sites in Europe…
  10. Oragenics, Inc. Receives Clearance to Enroll Patients in Germany and the United Kingdom into Its Phase 2 Clinical Trial of AG013 for Oral Mucositis
  11. Oragenics, Inc. Announces 3Q 2018 Financial Results and Provides Corporate Update
  12. Oragenics: 3Q Earnings Snapshot
  13. Positive Global Healthcare Outlook Could Push 3 Stocks Higher
  14. Today’s Research Reports on Stocks to Watch: Fresenius Medical Care and Oragenics
  15. Oragenics, Inc. Receives Clearance to Enroll Patients in Belgium into Its Phase 2 Clinical Trial of AG013 for Oral Mucositis
  16. Today's Research Reports on Trending Tickers: Oragenics and ACADIA Pharmaceuticals
  17. This Week’s Biotech and Cannabis Stocks to Watch
  18. Should You Worry About The Oragenics Inc’s (NYSEMKT:OGEN) Shareholder Register?
  19. These Stocks Are on The Brink of Breakouts
  20. SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Oragenics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors